Table of Content

1 Report Overview
1.1 Therapeutic Protein Definition
1.2 Market by Type
1.2.1 Global Therapeutic Protein Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Monoclonal Antibodies
1.2.3 Erythropoietin
1.2.4 Insulin
1.2.5 Interferon
1.2.6 Human Growth Hormone
1.2.7 Follicle Stimulating Hormone
1.2.8 Blood Clotting Factors
1.3 Market Segment by Application
1.3.1 Global Therapeutic Protein Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Pharmaceutical Companies
1.3.3 Healthcare Service Providers
1.3.4 Research Organizations
1.3.5 Academic Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Therapeutic Protein Sales
2.1 Global Therapeutic Protein Revenue Estimates and Forecasts 2018-2034
2.2 Global Therapeutic Protein Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Therapeutic Protein Revenue by Region
2.3.1 Global Therapeutic Protein Revenue by Region (2018-2024)
2.3.2 Global Therapeutic Protein Revenue by Region (2024-2034)
2.4 Global Therapeutic Protein Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Therapeutic Protein Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Therapeutic Protein Sales Quantity by Region
2.6.1 Global Therapeutic Protein Sales Quantity by Region (2018-2024)
2.6.2 Global Therapeutic Protein Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Therapeutic Protein Sales Quantity by Manufacturers
3.1.1 Global Therapeutic Protein Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Therapeutic Protein Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Therapeutic Protein Sales in 2022
3.2 Global Therapeutic Protein Revenue by Manufacturers
3.2.1 Global Therapeutic Protein Revenue by Manufacturers (2018-2024)
3.2.2 Global Therapeutic Protein Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Therapeutic Protein Revenue in 2022
3.3 Global Therapeutic Protein Sales Price by Manufacturers
3.4 Global Key Players of Therapeutic Protein, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Therapeutic Protein, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Therapeutic Protein, Product Offered and Application
3.8 Global Key Manufacturers of Therapeutic Protein, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Therapeutic Protein Sales Quantity by Type
4.1.1 Global Therapeutic Protein Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Therapeutic Protein Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Therapeutic Protein Sales Quantity Market Share by Type (2018-2034)
4.2 Global Therapeutic Protein Revenue by Type
4.2.1 Global Therapeutic Protein Historical Revenue by Type (2018-2024)
4.2.2 Global Therapeutic Protein Forecasted Revenue by Type (2024-2034)
4.2.3 Global Therapeutic Protein Revenue Market Share by Type (2018-2034)
4.3 Global Therapeutic Protein Price by Type
4.3.1 Global Therapeutic Protein Price by Type (2018-2024)
4.3.2 Global Therapeutic Protein Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Therapeutic Protein Sales Quantity by Application
5.1.1 Global Therapeutic Protein Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Therapeutic Protein Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Therapeutic Protein Sales Quantity Market Share by Application (2018-2034)
5.2 Global Therapeutic Protein Revenue by Application
5.2.1 Global Therapeutic Protein Historical Revenue by Application (2018-2024)
5.2.2 Global Therapeutic Protein Forecasted Revenue by Application (2024-2034)
5.2.3 Global Therapeutic Protein Revenue Market Share by Application (2018-2034)
5.3 Global Therapeutic Protein Price by Application
5.3.1 Global Therapeutic Protein Price by Application (2018-2024)
5.3.2 Global Therapeutic Protein Price Forecast by Application (2024-2034)
6 North America
6.1 North America Therapeutic Protein Sales by Company
6.1.1 North America Therapeutic Protein Revenue by Company (2018-2024)
6.1.2 North America Therapeutic Protein Sales Quantity by Company (2018-2024)
6.2 North America Therapeutic Protein Market Size by Type
6.2.1 North America Therapeutic Protein Sales Quantity by Type (2018-2034)
6.2.2 North America Therapeutic Protein Revenue by Type (2018-2034)
6.3 North America Therapeutic Protein Market Size by Application
6.3.1 North America Therapeutic Protein Sales Quantity by Application (2018-2034)
6.3.2 North America Therapeutic Protein Revenue by Application (2018-2034)
6.4 North America Therapeutic Protein Market Size by Country
6.4.1 North America Therapeutic Protein Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Therapeutic Protein Revenue by Country (2018-2034)
6.4.3 North America Therapeutic Protein Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Therapeutic Protein Sales by Company
7.1.1 Europe Therapeutic Protein Sales Quantity by Company (2018-2024)
7.1.2 Europe Therapeutic Protein Revenue by Company (2018-2024)
7.2 Europe Therapeutic Protein Market Size by Type
7.2.1 Europe Therapeutic Protein Sales Quantity by Type (2018-2034)
7.2.2 Europe Therapeutic Protein Revenue by Type (2018-2034)
7.3 Europe Therapeutic Protein Market Size by Application
7.3.1 Europe Therapeutic Protein Sales Quantity by Application (2018-2034)
7.3.2 Europe Therapeutic Protein Revenue by Application (2018-2034)
7.4 Europe Therapeutic Protein Market Size by Country
7.4.1 Europe Therapeutic Protein Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Therapeutic Protein Revenue by Country (2018-2034)
7.4.3 Europe Therapeutic Protein Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Therapeutic Protein Sales by Company
8.1.1 China Therapeutic Protein Sales Quantity by Company (2018-2024)
8.1.2 China Therapeutic Protein Revenue by Company (2018-2024)
8.2 China Therapeutic Protein Market Size by Type
8.2.1 China Therapeutic Protein Sales Quantity by Type (2018-2034)
8.2.2 China Therapeutic Protein Revenue by Type (2018-2034)
8.3 China Therapeutic Protein Market Size by Application
8.3.1 China Therapeutic Protein Sales Quantity by Application (2018-2034)
8.3.2 China Therapeutic Protein Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Therapeutic Protein Sales by Company
9.1.1 APAC Therapeutic Protein Sales Quantity by Company (2018-2024)
9.1.2 APAC Therapeutic Protein Revenue by Company (2018-2024)
9.2 APAC Therapeutic Protein Market Size by Type
9.2.1 APAC Therapeutic Protein Sales Quantity by Type (2018-2034)
9.2.2 APAC Therapeutic Protein Revenue by Type (2018-2034)
9.3 APAC Therapeutic Protein Market Size by Application
9.3.1 APAC Therapeutic Protein Sales Quantity by Application (2018-2034)
9.3.2 APAC Therapeutic Protein Revenue by Application (2018-2034)
9.4 APAC Therapeutic Protein Market Size by Region
9.4.1 APAC Therapeutic Protein Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Therapeutic Protein Revenue by Region (2018-2034)
9.4.3 APAC Therapeutic Protein Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Therapeutic Protein Sales by Company
10.1.1 Middle East, Africa and Latin America Therapeutic Protein Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Therapeutic Protein Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Therapeutic Protein Market Size by Type
10.2.1 Middle East, Africa and Latin America Therapeutic Protein Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Therapeutic Protein Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Therapeutic Protein Market Size by Application
10.3.1 Middle East, Africa and Latin America Therapeutic Protein Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Therapeutic Protein Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Therapeutic Protein Market Size by Country
10.4.1 Middle East, Africa and Latin America Therapeutic Protein Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Therapeutic Protein Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Therapeutic Protein Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Overview
11.1.3 Amgen Therapeutic Protein Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Amgen Therapeutic Protein Products and Services
11.1.5 Amgen Therapeutic Protein SWOT Analysis
11.1.6 Amgen Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Information
11.2.2 Abbott Laboratories Overview
11.2.3 Abbott Laboratories Therapeutic Protein Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Abbott Laboratories Therapeutic Protein Products and Services
11.2.5 Abbott Laboratories Therapeutic Protein SWOT Analysis
11.2.6 Abbott Laboratories Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Overview
11.3.3 AstraZeneca Therapeutic Protein Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 AstraZeneca Therapeutic Protein Products and Services
11.3.5 AstraZeneca Therapeutic Protein SWOT Analysis
11.3.6 AstraZeneca Recent Developments
11.4 Baxter International
11.4.1 Baxter International Company Information
11.4.2 Baxter International Overview
11.4.3 Baxter International Therapeutic Protein Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Baxter International Therapeutic Protein Products and Services
11.4.5 Baxter International Therapeutic Protein SWOT Analysis
11.4.6 Baxter International Recent Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Information
11.5.2 Boehringer Ingelheim Overview
11.5.3 Boehringer Ingelheim Therapeutic Protein Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Boehringer Ingelheim Therapeutic Protein Products and Services
11.5.5 Boehringer Ingelheim Therapeutic Protein SWOT Analysis
11.5.6 Boehringer Ingelheim Recent Developments
11.6 Chugai Pharmaceutical
11.6.1 Chugai Pharmaceutical Company Information
11.6.2 Chugai Pharmaceutical Overview
11.6.3 Chugai Pharmaceutical Therapeutic Protein Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Chugai Pharmaceutical Therapeutic Protein Products and Services
11.6.5 Chugai Pharmaceutical Therapeutic Protein SWOT Analysis
11.6.6 Chugai Pharmaceutical Recent Developments
11.7 Diasome Pharmaceuticals
11.7.1 Diasome Pharmaceuticals Company Information
11.7.2 Diasome Pharmaceuticals Overview
11.7.3 Diasome Pharmaceuticals Therapeutic Protein Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Diasome Pharmaceuticals Therapeutic Protein Products and Services
11.7.5 Diasome Pharmaceuticals Therapeutic Protein SWOT Analysis
11.7.6 Diasome Pharmaceuticals Recent Developments
11.8 Eli Lilly
11.8.1 Eli Lilly Company Information
11.8.2 Eli Lilly Overview
11.8.3 Eli Lilly Therapeutic Protein Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Eli Lilly Therapeutic Protein Products and Services
11.8.5 Eli Lilly Therapeutic Protein SWOT Analysis
11.8.6 Eli Lilly Recent Developments
11.9 GeneScience Pharmaceuticals
11.9.1 GeneScience Pharmaceuticals Company Information
11.9.2 GeneScience Pharmaceuticals Overview
11.9.3 GeneScience Pharmaceuticals Therapeutic Protein Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 GeneScience Pharmaceuticals Therapeutic Protein Products and Services
11.9.5 GeneScience Pharmaceuticals Therapeutic Protein SWOT Analysis
11.9.6 GeneScience Pharmaceuticals Recent Developments
11.10 Generex Biotechnology
11.10.1 Generex Biotechnology Company Information
11.10.2 Generex Biotechnology Overview
11.10.3 Generex Biotechnology Therapeutic Protein Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Generex Biotechnology Therapeutic Protein Products and Services
11.10.5 Generex Biotechnology Therapeutic Protein SWOT Analysis
11.10.6 Generex Biotechnology Recent Developments
11.11 Genentech
11.11.1 Genentech Company Information
11.11.2 Genentech Overview
11.11.3 Genentech Therapeutic Protein Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Genentech Therapeutic Protein Products and Services
11.11.5 Genentech Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Therapeutic Protein Value Chain Analysis
12.2 Therapeutic Protein Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Therapeutic Protein Production Mode & Process
12.4 Therapeutic Protein Sales and Marketing
12.4.1 Therapeutic Protein Sales Channels
12.4.2 Therapeutic Protein Distributors
12.5 Therapeutic Protein Customers
13 Market Dynamics
13.1 Therapeutic Protein Industry Trends
13.2 Therapeutic Protein Market Drivers
13.3 Therapeutic Protein Market Challenges
13.4 Therapeutic Protein Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Therapeutic Protein Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibodies
Table 3. Major Manufacturers of Erythropoietin
Table 4. Major Manufacturers of Insulin
Table 5. Major Manufacturers of Interferon
Table 6. Major Manufacturers of Human Growth Hormone
Table 7. Major Manufacturers of Follicle Stimulating Hormone
Table 8. Major Manufacturers of Blood Clotting Factors
Table 9. Global Therapeutic Protein Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 10. Global Therapeutic Protein Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 11. Global Therapeutic Protein Revenue by Region (2018-2024) & (US$ Million)
Table 12. Global Therapeutic Protein Revenue Market Share by Region (2018-2024)
Table 13. Global Therapeutic Protein Revenue by Region (2024-2034) & (US$ Million)
Table 14. Global Therapeutic Protein Revenue Market Share by Region (2024-2034)
Table 15. Global Therapeutic Protein Sales Quantity by Region: 2018 VS 2022 VS 2034 (K MT)
Table 16. Global Therapeutic Protein Sales by Region (2018-2024) & (K MT)
Table 17. Global Therapeutic Protein Sales Market Share by Region (2018-2024)
Table 18. Global Therapeutic Protein Sales by Region (2024-2034) & (K MT)
Table 19. Global Therapeutic Protein Sales Market Share by Region (2024-2034)
Table 20. Global Therapeutic Protein Sales Quantity by Manufacturers (2018-2024) & (K MT)
Table 21. Global Therapeutic Protein Sales Quantity Share by Manufacturers (2018-2024)
Table 22. Global Therapeutic Protein Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 23. Global Therapeutic Protein Revenue Share by Manufacturers (2018-2024)
Table 24. Global Therapeutic Protein Price by Manufacturers 2018-2024 (USD/MT)
Table 25. Global Key Players of Therapeutic Protein, Industry Ranking, 2021 VS 2022
Table 26. Global Therapeutic Protein Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Therapeutic Protein by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Protein as of 2022)
Table 28. Global Key Manufacturers of Therapeutic Protein, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of Therapeutic Protein, Product Offered and Application
Table 30. Global Key Manufacturers of Therapeutic Protein, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Therapeutic Protein Sales Quantity by Type (2018-2024) & (K MT)
Table 33. Global Therapeutic Protein Sales Quantity by Type (2024-2034) & (K MT)
Table 34. Global Therapeutic Protein Sales Quantity Share by Type (2018-2024)
Table 35. Global Therapeutic Protein Sales Quantity Share by Type (2024-2034)
Table 36. Global Therapeutic Protein Revenue by Type (2018-2024) & (US$ Million)
Table 37. Global Therapeutic Protein Revenue by Type (2024-2034) & (US$ Million)
Table 38. Global Therapeutic Protein Revenue Share by Type (2018-2024)
Table 39. Global Therapeutic Protein Revenue Share by Type (2024-2034)
Table 40. Therapeutic Protein Price by Type (2018-2024) & (USD/MT)
Table 41. Global Therapeutic Protein Price Forecast by Type (2024-2034) & (USD/MT)
Table 42. Global Therapeutic Protein Sales Quantity by Application (2018-2024) & (K MT)
Table 43. Global Therapeutic Protein Sales Quantity by Application (2024-2034) & (K MT)
Table 44. Global Therapeutic Protein Sales Quantity Share by Application (2018-2024)
Table 45. Global Therapeutic Protein Sales Quantity Share by Application (2024-2034)
Table 46. Global Therapeutic Protein Revenue by Application (2018-2024) & (US$ Million)
Table 47. Global Therapeutic Protein Revenue by Application (2024-2034) & (US$ Million)
Table 48. Global Therapeutic Protein Revenue Share by Application (2018-2024)
Table 49. Global Therapeutic Protein Revenue Share by Application (2024-2034)
Table 50. Therapeutic Protein Price by Application (2018-2024) & (USD/MT)
Table 51. Global Therapeutic Protein Price Forecast by Application (2024-2034) & (USD/MT)
Table 52. North America Therapeutic Protein Revenue by Company (2018-2024) & (US$ Million)
Table 53. North America Therapeutic Protein Sales Quantity by Company (2018-2024) & (K MT)
Table 54. North America Therapeutic Protein Sales Quantity by Type (2018-2024) & (K MT)
Table 55. North America Therapeutic Protein Sales Quantity by Type (2024-2034) & (K MT)
Table 56. North America Therapeutic Protein Revenue by Type (2018-2024) & (US$ Million)
Table 57. North America Therapeutic Protein Revenue by Type (2024-2034) & (US$ Million)
Table 58. North America Therapeutic Protein Sales Quantity by Application (2018-2024) & (K MT)
Table 59. North America Therapeutic Protein Sales Quantity by Application (2024-2034) & (K MT)
Table 60. North America Therapeutic Protein Revenue by Application (2018-2024) & (US$ Million)
Table 61. North America Therapeutic Protein Revenue by Application (2024-2034) & (US$ Million)
Table 62. North America Therapeutic Protein Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 63. North America Therapeutic Protein Revenue by Country (2018-2024) & (US$ Million)
Table 64. North America Therapeutic Protein Revenue by Country (2024-2034) & (US$ Million)
Table 65. North America Therapeutic Protein Sales Quantity by Country (2018-2024) & (K MT)
Table 66. North America Therapeutic Protein Sales Quantity by Country (2024-2034) & (K MT)
Table 67. Europe Therapeutic Protein Sales Quantity by Company (2018-2024) & (K MT)
Table 68. Europe Therapeutic Protein Revenue by Company (2018-2024) & (US$ Million)
Table 69. Europe Therapeutic Protein Sales Quantity by Type (2018-2024) & (K MT)
Table 70. Europe Therapeutic Protein Sales Quantity by Type (2024-2034) & (K MT)
Table 71. Europe Therapeutic Protein Revenue by Type (2018-2024) & (US$ Million)
Table 72. Europe Therapeutic Protein Revenue by Type (2024-2034) & (US$ Million)
Table 73. Europe Therapeutic Protein Sales Quantity by Application (2018-2024) & (K MT)
Table 74. Europe Therapeutic Protein Sales Quantity by Application (2024-2034) & (K MT)
Table 75. Europe Therapeutic Protein Revenue by Application (2018-2024) & (US$ Million)
Table 76. Europe Therapeutic Protein Revenue by Application (2024-2034) & (US$ Million)
Table 77. Europe Therapeutic Protein Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 78. Europe Therapeutic Protein Revenue by Country (2018-2024) & (US$ Million)
Table 79. Europe Therapeutic Protein Revenue by Country (2024-2034) & (US$ Million)
Table 80. Europe Therapeutic Protein Sales Quantity by Country (2018-2024) & (K MT)
Table 81. Europe Therapeutic Protein Sales Quantity by Country (2024-2034) & (K MT)
Table 82. China Therapeutic Protein Sales Quantity by Company (2018-2024) & (K MT)
Table 83. China Therapeutic Protein Revenue by Company (2018-2024) & (US$ Million)
Table 84. China Therapeutic Protein Sales Quantity by Type (2018-2024) & (K MT)
Table 85. China Therapeutic Protein Sales Quantity by Type (2024-2034) & (K MT)
Table 86. China Therapeutic Protein Revenue by Type (2018-2024) & (US$ Million)
Table 87. China Therapeutic Protein Revenue by Type (2024-2034) & (US$ Million)
Table 88. China Therapeutic Protein Sales Quantity by Application (2018-2024) & (K MT)
Table 89. China Therapeutic Protein Sales Quantity by Application (2024-2034) & (K MT)
Table 90. China Therapeutic Protein Revenue by Application (2018-2024) & (US$ Million)
Table 91. China Therapeutic Protein Revenue by Application (2024-2034) & (US$ Million)
Table 92. APAC Therapeutic Protein Sales Quantity by Company (2018-2024) & (K MT)
Table 93. APAC Therapeutic Protein Revenue by Company (2018-2024) & (US$ Million)
Table 94. APAC Therapeutic Protein Sales Quantity by Type (2018-2024) & (K MT)
Table 95. APAC Therapeutic Protein Sales Quantity by Type (2024-2034) & (K MT)
Table 96. APAC Therapeutic Protein Revenue by Type (2018-2024) & (US$ Million)
Table 97. APAC Therapeutic Protein Revenue by Type (2024-2034) & (US$ Million)
Table 98. APAC Therapeutic Protein Sales Quantity by Application (2018-2024) & (K MT)
Table 99. APAC Therapeutic Protein Sales Quantity by Application (2024-2034) & (K MT)
Table 100. APAC Therapeutic Protein Revenue by Application (2018-2024) & (US$ Million)
Table 101. APAC Therapeutic Protein Revenue by Application (2024-2034) & (US$ Million)
Table 102. APAC Therapeutic Protein Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 103. APAC Therapeutic Protein Revenue by Region (2018-2024) & (US$ Million)
Table 104. APAC Therapeutic Protein Revenue by Region (2024-2034) & (US$ Million)
Table 105. APAC Therapeutic Protein Sales Quantity by Region (2018-2024) & (K MT)
Table 106. APAC Therapeutic Protein Sales Quantity by Region (2024-2034) & (K MT)
Table 107. Middle East, Africa and Latin America Therapeutic Protein Sales Quantity by Company (2018-2024) & (K MT)
Table 108. Middle East, Africa and Latin America Therapeutic Protein Revenue by Company (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Therapeutic Protein Sales Quantity by Type (2018-2024) & (K MT)
Table 110. Middle East, Africa and Latin America Therapeutic Protein Sales Quantity by Type (2024-2034) & (K MT)
Table 111. Middle East, Africa and Latin America Therapeutic Protein Revenue by Type (2018-2024) & (US$ Million)
Table 112. Middle East, Africa and Latin America Therapeutic Protein Revenue by Type (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Therapeutic Protein Sales Quantity by Application (2018-2024) & (K MT)
Table 114. Middle East, Africa and Latin America Therapeutic Protein Sales Quantity by Application (2024-2034) & (K MT)
Table 115. Middle East, Africa and Latin America Therapeutic Protein Revenue by Application (2018-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Therapeutic Protein Revenue by Application (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Therapeutic Protein Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 118. Middle East, Africa and Latin America Therapeutic Protein Revenue by Country (2018-2024) & (US$ Million)
Table 119. Middle East, Africa and Latin America Therapeutic Protein Revenue by Country (2024-2034) & (US$ Million)
Table 120. Middle East, Africa and Latin America Therapeutic Protein Sales Quantity by Country (2018-2024) & (K MT)
Table 121. Middle East, Africa and Latin America Therapeutic Protein Sales Quantity by Country (2024-2034) & (K MT)
Table 122. Amgen Company Information
Table 123. Amgen Description and Overview
Table 124. Amgen Therapeutic Protein Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 125. Amgen Therapeutic Protein Product and Services
Table 126. Amgen Therapeutic Protein SWOT Analysis
Table 127. Amgen Recent Developments
Table 128. Abbott Laboratories Company Information
Table 129. Abbott Laboratories Description and Overview
Table 130. Abbott Laboratories Therapeutic Protein Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 131. Abbott Laboratories Therapeutic Protein Product and Services
Table 132. Abbott Laboratories Therapeutic Protein SWOT Analysis
Table 133. Abbott Laboratories Recent Developments
Table 134. AstraZeneca Company Information
Table 135. AstraZeneca Description and Overview
Table 136. AstraZeneca Therapeutic Protein Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 137. AstraZeneca Therapeutic Protein Product and Services
Table 138. AstraZeneca Therapeutic Protein SWOT Analysis
Table 139. AstraZeneca Recent Developments
Table 140. Baxter International Company Information
Table 141. Baxter International Description and Overview
Table 142. Baxter International Therapeutic Protein Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 143. Baxter International Therapeutic Protein Product and Services
Table 144. Baxter International Therapeutic Protein SWOT Analysis
Table 145. Baxter International Recent Developments
Table 146. Boehringer Ingelheim Company Information
Table 147. Boehringer Ingelheim Description and Overview
Table 148. Boehringer Ingelheim Therapeutic Protein Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 149. Boehringer Ingelheim Therapeutic Protein Product and Services
Table 150. Boehringer Ingelheim Therapeutic Protein SWOT Analysis
Table 151. Boehringer Ingelheim Recent Developments
Table 152. Chugai Pharmaceutical Company Information
Table 153. Chugai Pharmaceutical Description and Overview
Table 154. Chugai Pharmaceutical Therapeutic Protein Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 155. Chugai Pharmaceutical Therapeutic Protein Product and Services
Table 156. Chugai Pharmaceutical Therapeutic Protein SWOT Analysis
Table 157. Chugai Pharmaceutical Recent Developments
Table 158. Diasome Pharmaceuticals Company Information
Table 159. Diasome Pharmaceuticals Description and Overview
Table 160. Diasome Pharmaceuticals Therapeutic Protein Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 161. Diasome Pharmaceuticals Therapeutic Protein Product and Services
Table 162. Diasome Pharmaceuticals Therapeutic Protein SWOT Analysis
Table 163. Diasome Pharmaceuticals Recent Developments
Table 164. Eli Lilly Company Information
Table 165. Eli Lilly Description and Overview
Table 166. Eli Lilly Therapeutic Protein Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 167. Eli Lilly Therapeutic Protein Product and Services
Table 168. Eli Lilly Therapeutic Protein SWOT Analysis
Table 169. Eli Lilly Recent Developments
Table 170. GeneScience Pharmaceuticals Company Information
Table 171. GeneScience Pharmaceuticals Description and Overview
Table 172. GeneScience Pharmaceuticals Therapeutic Protein Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 173. GeneScience Pharmaceuticals Therapeutic Protein Product and Services
Table 174. GeneScience Pharmaceuticals Therapeutic Protein SWOT Analysis
Table 175. GeneScience Pharmaceuticals Recent Developments
Table 176. Generex Biotechnology Company Information
Table 177. Generex Biotechnology Description and Overview
Table 178. Generex Biotechnology Therapeutic Protein Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 179. Generex Biotechnology Therapeutic Protein Product and Services
Table 180. Generex Biotechnology Therapeutic Protein SWOT Analysis
Table 181. Generex Biotechnology Recent Developments
Table 182. Genentech Company Information
Table 183. Genentech Description and Overview
Table 184. Genentech Therapeutic Protein Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 185. Genentech Therapeutic Protein Product and Services
Table 186. Genentech Recent Developments
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Therapeutic Protein Distributors List
Table 190. Therapeutic Protein Customers List
Table 191. Therapeutic Protein Market Trends
Table 192. Therapeutic Protein Market Drivers
Table 193. Therapeutic Protein Market Challenges
Table 194. Therapeutic Protein Market Restraints
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Therapeutic Protein Product Picture
Figure 2. Global Therapeutic Protein Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Therapeutic Protein Market Share by Type in 2022 & 2034
Figure 4. Monoclonal Antibodies Product Picture
Figure 5. Erythropoietin Product Picture
Figure 6. Insulin Product Picture
Figure 7. Interferon Product Picture
Figure 8. Human Growth Hormone Product Picture
Figure 9. Follicle Stimulating Hormone Product Picture
Figure 10. Blood Clotting Factors Product Picture
Figure 11. Global Therapeutic Protein Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 12. Global Therapeutic Protein Market Share by Application in 2022 & 2034
Figure 13. Pharmaceutical Companies
Figure 14. Healthcare Service Providers
Figure 15. Research Organizations
Figure 16. Academic Research Institutes
Figure 17. Therapeutic Protein Report Years Considered
Figure 18. Global Therapeutic Protein Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 19. Global Therapeutic Protein Revenue 2018-2034 (US$ Million)
Figure 20. Global Therapeutic Protein Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 21. Global Therapeutic Protein Sales Quantity 2018-2034 (K MT)
Figure 22. Global Therapeutic Protein Sales Quantity Market Share by Region (2018-2024)
Figure 23. Global Therapeutic Protein Sales Quantity Market Share by Region (2024-2034)
Figure 24. North America Therapeutic Protein Sales Quantity YoY (2018-2034) & (K MT)
Figure 25. North America Therapeutic Protein Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Europe Therapeutic Protein Sales Quantity YoY (2018-2034) & (K MT)
Figure 27. Europe Therapeutic Protein Revenue YoY (2018-2034) & (US$ Million)
Figure 28. China Therapeutic Protein Sales Quantity YoY (2018-2034) & (K MT)
Figure 29. China Therapeutic Protein Revenue YoY (2018-2034) & (US$ Million)
Figure 30. APAC Therapeutic Protein Sales Quantity YoY (2018-2034) & (K MT)
Figure 31. APAC Therapeutic Protein Revenue YoY (2018-2034) & (US$ Million)
Figure 32. Middle East, Africa and Latin America Therapeutic Protein Sales Quantity YoY (2018-2034) & (K MT)
Figure 33. Middle East, Africa and Latin America Therapeutic Protein Revenue YoY (2018-2034) & (US$ Million)
Figure 34. The Top 10 and Top 5 Players Market Share by Therapeutic Protein Sales Quantity in 2022
Figure 35. The Top 10 and Top 5 Players Market Share by Therapeutic Protein Revenue in 2022
Figure 36. Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 37. Global Therapeutic Protein Sales Quantity Market Share by Type (2018-2034)
Figure 38. Global Therapeutic Protein Revenue Market Share by Type (2018-2034)
Figure 39. Global Therapeutic Protein Sales Quantity Market Share by Application (2018-2034)
Figure 40. Global Therapeutic Protein Revenue Market Share by Application (2018-2034)
Figure 41. North America Therapeutic Protein Revenue Market Share by Company in 2022
Figure 42. North America Therapeutic Protein Sales Quantity Market Share by Company in 2022
Figure 43. North America Therapeutic Protein Sales Quantity Market Share by Type (2018-2034)
Figure 44. North America Therapeutic Protein Revenue Market Share by Type (2018-2034)
Figure 45. North America Therapeutic Protein Sales Quantity Market Share by Application (2018-2034)
Figure 46. North America Therapeutic Protein Revenue Market Share by Application (2018-2034)
Figure 47. North America Therapeutic Protein Revenue Share by Country (2018-2034)
Figure 48. North America Therapeutic Protein Sales Quantity Share by Country (2018-2034)
Figure 49. U.S. Therapeutic Protein Revenue (2018-2034) & (US$ Million)
Figure 50. Canada Therapeutic Protein Revenue (2018-2034) & (US$ Million)
Figure 51. Europe Therapeutic Protein Sales Quantity Market Share by Company in 2022
Figure 52. Europe Therapeutic Protein Revenue Market Share by Company in 2022
Figure 53. Europe Therapeutic Protein Sales Quantity Market Share by Type (2018-2034)
Figure 54. Europe Therapeutic Protein Revenue Market Share by Type (2018-2034)
Figure 55. Europe Therapeutic Protein Sales Quantity Market Share by Application (2018-2034)
Figure 56. Europe Therapeutic Protein Revenue Market Share by Application (2018-2034)
Figure 57. Europe Therapeutic Protein Revenue Share by Country (2018-2034)
Figure 58. Europe Therapeutic Protein Sales Quantity Share by Country (2018-2034)
Figure 59. Germany Therapeutic Protein Revenue (2018-2034) & (US$ Million)
Figure 60. France Therapeutic Protein Revenue (2018-2034) & (US$ Million)
Figure 61. U.K. Therapeutic Protein Revenue (2018-2034) & (US$ Million)
Figure 62. Italy Therapeutic Protein Revenue (2018-2034) & (US$ Million)
Figure 63. Russia Therapeutic Protein Revenue (2018-2034) & (US$ Million)
Figure 64. China Therapeutic Protein Sales Quantity Market Share by Company in 2022
Figure 65. China Therapeutic Protein Revenue Market Share by Company in 2022
Figure 66. China Therapeutic Protein Sales Quantity Market Share by Type (2018-2034)
Figure 67. China Therapeutic Protein Revenue Market Share by Type (2018-2034)
Figure 68. China Therapeutic Protein Sales Quantity Market Share by Application (2018-2034)
Figure 69. China Therapeutic Protein Revenue Market Share by Application (2018-2034)
Figure 70. APAC Therapeutic Protein Sales Quantity Market Share by Company in 2022
Figure 71. APAC Therapeutic Protein Revenue Market Share by Company in 2022
Figure 72. APAC Therapeutic Protein Sales Quantity Market Share by Type (2018-2034)
Figure 73. APAC Therapeutic Protein Revenue Market Share by Type (2018-2034)
Figure 74. APAC Therapeutic Protein Sales Quantity Market Share by Application (2018-2034)
Figure 75. APAC Therapeutic Protein Revenue Market Share by Application (2018-2034)
Figure 76. APAC Therapeutic Protein Revenue Share by Region (2018-2034)
Figure 77. APAC Therapeutic Protein Sales Quantity Share by Region (2018-2034)
Figure 78. Japan Therapeutic Protein Revenue (2018-2034) & (US$ Million)
Figure 79. South Korea Therapeutic Protein Revenue (2018-2034) & (US$ Million)
Figure 80. China Taiwan Therapeutic Protein Revenue (2018-2034) & (US$ Million)
Figure 81. Southeast Asia Therapeutic Protein Revenue (2018-2034) & (US$ Million)
Figure 82. India Therapeutic Protein Revenue (2018-2034) & (US$ Million)
Figure 83. Middle East, Africa and Latin America Therapeutic Protein Sales Quantity Market Share by Company in 2022
Figure 84. Middle East, Africa and Latin America Therapeutic Protein Revenue Market Share by Company in 2022
Figure 85. Middle East, Africa and Latin America Therapeutic Protein Sales Quantity Market Share by Type (2018-2034)
Figure 86. Middle East, Africa and Latin America Therapeutic Protein Revenue Market Share by Type (2018-2034)
Figure 87. Middle East, Africa and Latin America Therapeutic Protein Sales Quantity Market Share by Application (2018-2034)
Figure 88. Middle East, Africa and Latin America Therapeutic Protein Revenue Market Share by Application (2018-2034)
Figure 89. Middle East, Africa and Latin America Therapeutic Protein Sales Quantity Share by Country (2018-2034)
Figure 90. Middle East, Africa and Latin America Therapeutic Protein Revenue Share by Country (2018-2034)
Figure 91. Brazil Therapeutic Protein Revenue (2018-2034) & (US$ Million)
Figure 92. Mexico Therapeutic Protein Revenue (2018-2034) & (US$ Million)
Figure 93. Turkey Therapeutic Protein Revenue (2018-2034) & (US$ Million)
Figure 94. Israel Therapeutic Protein Revenue (2018-2034) & (US$ Million)
Figure 95. GCC Countries Therapeutic Protein Revenue (2018-2034) & (US$ Million)
Figure 96. Therapeutic Protein Value Chain
Figure 97. Therapeutic Protein Production Process
Figure 98. Channels of Distribution (Direct Vs Distribution)
Figure 99. Distributors Profiles
Figure 100. Bottom-up and Top-down Approaches for This Report
Figure 101. Data Triangulation
Figure 102. Key Executives Interviewed